Evaluation of comparative effectiveness research: a practical tool

Journal of Comparative Effectiveness Research
Debra A SchaumbergSreeram V Ramagopalan

Abstract

Comparative effectiveness research (CER) guidelines have been developed to direct the field toward the most rigorous study methodologies. A challenge, however, is how to ensure the best evidence is generated, and how to translate methodologically complex or nuanced CER findings into usable medical evidence. To reach that goal, it is important that both researchers and end users of CER output become knowledgeable about the elements that impact the quality and interpretability of CER. This paper distilled guidance on CER into a practical tool to assist both researchers and nonexperts with the critical review and interpretation of CER, with a focus on issues particularly relevant to CER in oncology.

References

Mar 1, 1981·American Journal of Public Health·C PercyL Gloeckler
Dec 1, 1996·Journal of Clinical Epidemiology·P PeduzziA R Feinstein
Dec 6, 2001·Journal of the National Cancer Institute·D F PensonJ L Stanford
Oct 31, 2003·American Journal of Epidemiology·Wayne A Ray
Apr 14, 2006·Basic & Clinical Pharmacology & Toxicology·Robert J GlynnTil Stürmer
Jul 11, 2006·The New England Journal of Medicine·David Cunningham MAGIC Trial Participants
Apr 25, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Malcolm J MooreUNKNOWN National Cancer Institute of Canada Clinical Trials Group
May 8, 2007·European Journal of Epidemiology·Rolf H H GroenwoldEelko Hak
Nov 27, 2007·Nature Clinical Practice. Rheumatology·Samy Suissa, Edeltraut Garbe
Dec 7, 2007·American Journal of Epidemiology·Samy Suissa
Jul 1, 2008·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·V Paul Doria-Rose, Pamela M Marcus
May 18, 2010·Medical Care·M Alan BrookhartSebastian Schneeweiss
Jun 30, 2010·Clinical Orthopaedics and Related Research·Frederick J Dorey
May 16, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephen R SmalleyJohn S Macdonald
Oct 17, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·George P Browman
Nov 19, 2013·Journal of Comparative Effectiveness Research·Nancy A Dreyer
Oct 7, 2015·PLoS Medicine·Eric I BenchimolUNKNOWN RECORD Working Committee
Jan 10, 2016·JAMA Internal Medicine·Dong Wook ShinEliseo Guallar
Sep 27, 2016·Journal of Managed Care & Specialty Pharmacy·Nancy A DreyerPriscilla Velentgas
Feb 17, 2017·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Jennifer M YehDeborah Schrag
May 4, 2017·Journal of Clinical Epidemiology·Adam J StreeterWilliam E Henley

❮ Previous
Next ❯

Citations

Jan 9, 2019·Journal of Comparative Effectiveness Research·Tine GeldofIsabelle Huys
Dec 29, 2020·Acta Ophthalmologica·Robert P FingerJean-François Korobelnik
Jun 2, 2021·Journal of Comparative Effectiveness Research·David GuyGeorge Rodrigues

❮ Previous
Next ❯

Software Mentioned

Google Scholar
CER

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.